الصفحة الرئيسية>>Peptides>>Goserelin acetate

Goserelin acetate

رقم الكتالوجGC36180

Goserelin acetate (ICI-118630 acetate) ، وهو نظير ديكاببتيد للهرمون المطلق لموجهة الغدد التناسلية (GnRH / LHRH) ، يعمل كمحفز لـ GnRH

Products are for research use only. Not for human use. We do not sell to patients.

Goserelin acetate التركيب الكيميائي

Cas No.: 145781-92-6

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
135٫00
متوفر
5mg
64٫00
متوفر
10mg
93٫00
متوفر
50mg
324٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Goserelin acetate (ICI 118630 acetate) is an injectable gonadotropin releasing hormone superagonist (GnRH agonist).IC50 value:Target: GnRH agonistGoserelin is used to treat hormone-sensitive cancers of the breast (in pre- and peri- menopausal women) and prostate, and some benign gynaecological disorders (endometriosis, uterine fibroids and endometrial thinning). In addition, goserelin is used in assisted reproduction and in the treatment of precocious puberty. It may also be used in the treatment of male-to-female transsexuals and is favoured above other anti-androgens in some countries, such as the UK. It is available as a 1-month depot and a long-acting 3-month depot. Goserelin stimulates the production of the sex hormones testosterone and estrogen in a non-pulsatile (non-physiological) manner.

مراجعات

Review for Goserelin acetate

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Goserelin acetate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.